Antibiotic treatment of acute bacterial skin and skin structure infections

Area of Science:

• Infectious Diseases
• Dermatology
• Microbiology

Background:

• Acute bacterial skin and skin structure infections (ABSSSI) are a significant cause of illness.
• The prevalence of multidrug-resistant (MDR) strains, including MRSA and resistant Gram-negatives, is a growing concern.
• ABSSSI present with diverse clinical features, complicating diagnosis and treatment.

Purpose of the Study:

• To review the current clinical management strategies for ABSSSI.
• To highlight the importance of accurate diagnosis and risk factor assessment for MDR pathogens.
• To guide appropriate antibiotic selection and therapy monitoring in ABSSSI patients.

Main Methods:

• Review of current clinical guidelines and literature on ABSSSI management.
• Analysis of diagnostic criteria for identifying high-risk patients.
• Evaluation of therapeutic approaches based on pathogen prevalence and antimicrobial resistance.

Main Results:

• Accurate diagnosis and identification of risk factors for MDR pathogens are crucial for effective ABSSSI therapy.
• Patient risk stratification involves considering both disease-specific and host-associated factors.
• Antibiotic selection should align with the clinical presentation, likely pathogens, and local resistance data.

Conclusions:

• Tailored antibiotic therapy, reassessed after 48-72 hours, is essential for successful ABSSSI treatment.
• Vigilant monitoring of patients with comorbidities or risk factors for treatment failure is necessary.
• Effective management of ABSSSI requires a comprehensive approach addressing diagnosis, risk stratification, and antimicrobial stewardship.